You should speak with a provider before considering BPC-157 if you: Have a chronic medical condition Take prescription medications Have immune system concerns Have a history of cancer Are pregnant or breastfeeding Are recovering from surgery Have ongoing pain or unexplained inflammation Are using other peptides, hormones, or performance compounds BPC-157 should not replace proper diagnosis, imaging, rehab, or medical treatment for injuries
Requires a valid prescription from a licensed medical provider
If a supplement has low bioavailability, most of it ends up being wasted and can cause the very digestive issues we are discussing
Today, many individuals purchase the substances directly from manufacturers in China, or from companies in the US and the UK which import the substances and then mayor may notdo third-party testing for purity
Currently, cagrilintide remains investigational and available only as a research chemical pending FDA approval expected 2025-2026